[Federal Register Volume 63, Number 110 (Tuesday, June 9, 1998)]
[Notices]
[Page 31513]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-15338]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration
[Docket No. 98N-0285]


Sanofi Pharmaceuticals, Inc., et al.; Withdrawal of Approval of 
21 New Drug Applications and 62 Abbreviated New Drug Applications; 
Correction

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; correction.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is correcting a 
document that appeared in the Federal Register of May 12, 1998 (62 FR 
26191). The document announced the withdrawal of approval of 21 new 
drug applications (NDA's) and 62 abbreviated new drug applications 
(ANDA's). The document was published with an error in the 
identification of NDA for Pipanol Powder and Tablets (trihyphenidyl) 
held by Sanofi Pharmaceuticals, Inc. This document corrects that error.

EFFECTIVE DATE: June 11, 1998.

FOR FURTHER INFORMATION CONTACT: Olivia A. Pritzlaff, Center for Drug 
Evaluation and Research (HFD-7), Food and Drug Administration, 5600 
Fishers Lane, Rockville, MD 20857, 301-594-2041.
    In FR Doc. 98-12613, appearing on page 26191 in the Federal 
Register of Tuesday, May 12, 1998, the following correction is made:
    On page 26191, in the table, in the first column, the first entry 
``NDA 4-496'' is corrected to read ``NDA 7-796''.

    Dated: June 3, 1998.
William K. Hubbard,
Associate Commissioner for Policy Coordination.
[FR Doc. 98-15338 Filed 6-8-98; 8:45 am]
BILLING CODE 4160-01-F